Ataluren
CAS 775304-57-9 1 API supplierSmall Molecule
Overview
Ataluren is a small-molecule investigational drug designed to facilitate ribosomal readthrough of premature stop codons in mRNA. It is being developed for the treatment of genetic disorders caused by nonsense mutations, such as Duchenne Muscular Dystrophy.
API suppliers (1)
Suppliers of Ataluren evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
Therapeutic areas
Muscular DystrophyGenetic Disorders
Verified Supplier Partner
Do you supply Ataluren? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.